PPD Inc. is wholly owned by Thermo Fisher Scientific following a major multi-billion-dollar cash acquisition that integrated the prominent clinical research organization into Thermo Fisher's extensive laboratory products and pharmaceutical services division. Under the acquisition terms, public shareholders received cash per share, and PPD ceased trading as an independent corporate entity on public stock exchanges.